Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer

被引:11
|
作者
Yun, Chen [2 ]
Gang, Li [1 ]
Gu Rongmin [1 ]
Xu, Wen [1 ]
Ming Xuezhi [1 ]
Chen Huanqiu [1 ]
机构
[1] Nanjing Med Univ, Dept Gen Surg, Gastr Tumor Ctr, Jiangsu Canc Hosp,Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210009, Jiangsu, Peoples R China
基金
中国博士后科学基金;
关键词
Her2; Her3; Met; gastric cancer; BREAST-CANCER; TARGETED THERAPIES; RECEPTOR; RESISTANCE; MECHANISMS;
D O I
10.1002/mc.22241
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various receptor tyrosine kinase (RTK) pathways were verified in many cancers including gastric cancer (GC), We sought to investigate the expression of RTKs including Her2, Her3, and Met and their transduction patterns in human GC. Over-expression of Her2, Her3, and c-Met in human GC was verified by immunohistochemistry leading to constitutive activation of RTK signaling pathways. Combined RTKs expression was valuable indicators for poor prognosis of GC patients. Using ErbB2 specific inhibitor Lapatinib and c-Met specific inhibitor PHA-665752, we further demonstrated that this constitutive activation of RTK signaling is necessary for the survival of GC cells. However, various RTK pattern: Her3/Her2 and Met/Her3 were verified in the transduction growth stimulus from outside via both AKT and MAPK signaling. Moreover, the essential roles of Her3 in both two heterodimers were obtained which showed significantly attenuated growth effect due to Her3 knockdown both in vitro and in vivo. In conclusion, various molecular transduction patterns: Her2/Her3 and Met/Her3 were verified in human GC, and Her3 could serve as a potential target in GC treatment. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1700 / 1709
页数:10
相关论文
共 50 条
  • [1] The role of HER3 in gastric cancer
    Wang, Liying
    Yuan, Hengheng
    Li, Yanjing
    Han, Yu
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (06) : 809 - 812
  • [2] HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways
    Choi, Byung-Kwon
    Cai, Xiumei
    Yuan, Bin
    Huang, Zhao
    Fan, Xuejun
    Deng, Hui
    Zhang, Ningyan
    An, Zhiqiang
    [J]. PROTEIN & CELL, 2012, 3 (10) : 781 - 789
  • [3] HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways
    ByungKwon Choi
    Xiumei Cai
    Bin Yuan
    Zhao Huang
    Xuejun Fan
    Hui Deng
    Ningyan Zhang
    Zhiqiang An
    [J]. Protein & Cell., 2012, 3 (10) - 789
  • [4] HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib
    Wehrenberg-Klee, Eric
    Sinevici, Nicoleta
    Nesti, Sarah
    Kalomeris, Taylor
    Austin, Emily
    Larimer, Benjamin
    Mahmood, Umar
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (06) : 930 - 940
  • [5] Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
    Xiu Li Zhang
    Yun Sheng Yang
    Dong Ping Xu
    Jian Hui Qu
    Ming Zhou Guo
    Yan Gong
    Jin Huang
    [J]. World Journal of Surgery, 2009, 33 : 2112 - 2118
  • [6] HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib
    Eric Wehrenberg-Klee
    Nicoleta Sinevici
    Sarah Nesti
    Taylor Kalomeris
    Emily Austin
    Benjamin Larimer
    Umar Mahmood
    [J]. Molecular Imaging and Biology, 2021, 23 : 930 - 940
  • [7] Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
    Zhang, Xiu Li
    Yang, Yun Sheng
    Xu, Dong Ping
    Qu, Jian Hui
    Guo, Ming Zhou
    Gong, Yan
    Huang, Jin
    [J]. WORLD JOURNAL OF SURGERY, 2009, 33 (10) : 2112 - 2118
  • [8] The role of the HER2 and HER3 in prostate cancer and their potential as therapeutic targets
    Rao, K.
    Gaughan, L.
    Robson, C.
    McCracken, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S177
  • [9] Overexpression of HER2/HER3 and clinical feature of ovarian cancer
    Chung, Ye Won
    Kim, Seongmin
    Hong, Jin Hwa
    Lee, Jae Kwan
    Lee, Nak Woo
    Lee, Young Seok
    Song, Jae Yun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (05)
  • [10] HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer
    Saddawi-Konefka, Robert
    Schokrpur, Shiruyeh
    Lui, Asona J.
    Gutkind, J. Silvio
    [J]. CANCER JOURNAL, 2022, 28 (05): : 339 - 345